Trial Profile
The Safety of SGLT2-i Dapagliflozin on Treating Blood Glucose Levels in SLE
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 05 Mar 2018 New trial record